Background
==========

The prevalence of chronic kidney disease (CKD) in the general population has been predicted to be between 6.8% and more than one-fifth \[[@B1]-[@B3]\], depending on the age and ethnicity of the target population. Two conditions have been utilized to diagnose CKD; low estimated glomerular filtration rate (eGFR) and high albuminuria, although the presence or absence of CKD is sometimes defined solely on the basis of eGFR data. Considering that both low eGFR and high albuminuria are both associated with cardiovascular morbidity, mortality \[[@B4]\], and end-stage renal disease \[[@B5]\], CKD is recognized as a major public health problem.

Several previous studies have suggested that oxidative stress is associated with and involved in the pathogenesis of CKD and its complications \[[@B6],[@B7]\]. Oxidative stress in CKD is presumed to be caused by a combination of increased production of reactive oxygen species \[[@B8]\] and impaired antioxidant capacity \[[@B9]\], and an enhancement of oxidative stress may also occur alongside the two frequently associated conditions, hypertension and diabetes. The findings that antioxidant therapy improved vascular function \[[@B10]\] and disease pathologies \[[@B11]\] may further support this notion.

These observations suggest that monitoring oxidative stress and antioxidant potential in vivo will provide crucial information for avoiding the progression of CKD and life-threatening events related to CKD; however, most of the methods for measuring these parameters may not be applicable to screening a low-risk general population of large size owing to the complexity of the analytical methodology, and cost. Recently, automated methods for the measurement of derivatives of reactive oxygen metabolites (d-ROMs) and biological antioxidant potential (BAP) have become available \[[@B12],[@B13]\]. To this end, we assessed whether CKD, low eGFR and high albuminuria, are associated with enhanced oxidative stress and antioxidant potential in individuals who underwent general health screening.

Methods
=======

Study population
----------------

The study was approved by the Ethics Committees of Mitsui Memorial Hospital and Osaka Medical College. This study was following the Guideline for Epidemiological Studies; therefore, written informed consent was not taken from each potential study participants. The study population comprised 8335 individuals aged ≥ 20 years (2958 women, 5377 men) who underwent a general health screening test and including the measurement of serum markers for oxidant status as well as blood pressure, renal function and extent of proteinuria (urinary excretion and creatinine excretion) between 2008 and 2012. In Japan, regular health check-ups for employees are mandated by law and, therefore, the majority of the study subjects did not have serious health problems. Blood pressure was measured after about 10 min of rest by an automated sphygmomanometer. In the current study, high blood pressure was defined to be present when systolic blood pressure was ≥ 140 mmHg and/or diastolic blood pressure was ≥ 90 mmHg.

Laboratory analysis
-------------------

Blood samples were taken from subjects after an overnight fast. Blood chemistry was performed as described previously \[[@B14]\]. Both the oxidative stress level and antioxidant properties in serum were determined by an automated method as described previously. In brief, the oxidative stress level was assessed via a d-ROMs test (Diacron s.r.l., Italy) \[[@B15],[@B16]\] and antioxidant potential was assessed via a BAP test (Diacron s.r.l.) \[[@B17],[@B18]\] using an automatic analyzer. When serum sample is dissolved in an acidic buffer of d-ROM test, the hydroperoxides react with the transition metal ions that are liberated from the protein in the acidic medium, resulting in an conversion to proxy and peroxyl radicals, which are able to oxidize N,N-diethyl-para-phenylenediamine which can eventually be detected spectrophotometrically \[[@B12],[@B19]\]. For the determination of antioxidant potential, BAP test measures of antioxidants as agents that can reduce iron from ferric (Fe^3+^) to ferrous form (Fe^2+^), and chromatic change of this reaction will be measured photometrically \[[@B20]\]. Measurements obtained in the d-ROMs and BAP tests were expressed as Carr units \[[@B21]\] and μmol/L, respectively. eGFR was calculated on the basis of the new Japanese coefficient-modified Modification of Diet in Renal disease (MDRD) study equation \[[@B22]\]: eGFR (mL/min/1.73 m^2^) = 194 × (serum creatinine)^-1.094^ × (age)^-0.287^ (× 0.739, when female). For the diagnosis of albuminuria, spot urine samples were collected and calculated on the basis of 1 g of urinary creatinine; increased albuminuria was defined to be present when the urinary albumin-to-creatinine ratio (urinary albumin excretion ratio, UAER) was ≥ 30 (mg/g·creatinine), and micro- and macro-albuminuria was defined when UAER (mg/g ·creatinine) was 30-300 and ≥ 300, respectively.

Statistical analysis
--------------------

Data analysis was performed by using IBM SPSS statistics version 21.0 (SPSS, Chicago, IL). Continuous variables are expressed as the mean ± standard deviation or median and interquartile range, and dichotomous variables are expressed as number and percentage, unless stated otherwise. Differences between groups were calculated by analysis of variance (ANOVA), Dunnett's post hoc analysis, and χ^2^ tests, where appropriate. Correlations between variables tested were assessed by Spearman\'s correlation coefficient. In the logistic regression analysis, age, high blood pressure, antihypertensive drug use, smoking (former, current), the quartiles of GFR and UAER were used as independent variables. A value of p \< 0.05 was taken to be statistically significant.

Results
=======

Characteristics of Individuals
------------------------------

The mean age of the study subjects was 59.7 ± 10.4 years, and did not differ significantly between women and men (Table [1](#T1){ref-type="table"}). Both d-ROM and BAP values were significantly higher in women than in men. By Spearman's test, d-ROM and BAP showed positive, albeit very weak, correlation in either gender (Table [2](#T2){ref-type="table"}). Correlation between log(eGFR) and d-ROM was not significant in either gender, and that between log(UAER) and BAP was not significant in women (Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}, Table [2](#T2){ref-type="table"}).

###### 

Baseline characteristics

                                    **Whole subjects**                   **Women**                   **Men**                   **P value**                             
  -------------------------------- -------------------- --- ------ ---- ----------- --- ------- --- --------- ---- ------ --- ------------- --- ------ ---- ------ --- ---------
  No. of subjects                          8335                            2958                       5377                        0.862                                
  Age, years                               59.7          ±   10.4                        59.7    ±    10.1                        59.6       ±   10.5                   \<0.001
  BMI, kg/m^2^                             23.2          ±   3.3                         21.8    ±     3.3                        24.1       ±   3.1                    \<0.001
  Waist circumference, cm                  83.3          ±   9.4                         78.6    ±     9.5                        85.9       ±   8.3                    \<0.001
  Systolic blood pressure, mmHg           125.0          ±   17.7                        120.4   ±    18.7                        127.6      ±   16.6                   \<0.001
  Diastolic blood pressure, mmHg           78.3          ±   10.7                        74.4    ±    10.8                        80.6       ±   10.0                   \<0.001
  Heart rate, bpm                          62.5          ±   9.2                         63.2    ±     8.9                        62.2       ±   9.4                    \<0.001
  Laboratory data                                                                                                                                                      
   LDL Cholesterol, mg/dL                 124.0          ±   29.8                        127.2   ±    31.1                        122.3      ±   28.9                   \<0.001
   HDL Cholesterol, mg/dL                  62.0          ±   15.4                        69.7    ±    15.1                        57.8       ±   13.8                   \<0.001
   Triglycerides, mg/dL                    118           ±   76.6                         91     ±    46.7                         132       ±   85.4                   \<0.001
   C-reactive protein, mg/dL               0.04          (   0.02   \-     0.08      )   0.03    (    0.01     \-   0.06   )      0.04       (   0.02   \-   0.09   )   \<0.001
   FBS, mg/dL                             101.7          ±   19.1                        96.1    ±    17.1                        104.7      ±   19.5                   \<0.001
   HbA1C,%                                 5.5           ±   0.6                          5.4    ±     0.5                         5.5       ±   0.6                    \<0.001
   BUN, U/L                                14.9          ±   3.7                         14.4    ±     3.6                        15.1       ±   3.8                    \<0.001
   Creatinine, mg/dL                       0.8           ±   0.2                          0.6    ±     0.1                         0.9       ±   0.2                    \<0.001
   eGFR, mL/min/1.73 m^2^                  73.5          (   65.1   \-     82.6      )   75.6    (    66.5     \-   85.1   )      72.3       (   64.5   \-   81.4   )   \<0.001
   UAER, mg/g Cr                           5.8           (   3.3    \-     12.8      )    7.3    (     4.3     \-   14.5   )       5.0       (   2.9    \-   11.5   )   \<0.001
  Oxidative stress markers                                                                                                                                             
   d-ROM, CARR U                           338           ±    66                          369    ±     68                          321       ±    59                    \<0.001
   BAP, μmol/L                             2430          ±   251                         2468    ±     239                        2408       ±   255                    \<0.001
  Smoking status                                                                                                                                                       
   Never (%)                               4069          (   48.8   )                    2430    (    82.2     )                  1639       (   30.5   )               \<0.001
   Former (%)                              3118          (   37.4   )                     355    (    12.0     )                  2463       (   51.4   )                   
   Current (%)                             1148          (   13.8   )                     173    (     5.8     )                   975       (   18.1   )                   
  Medication                                                                                                                                                           
   Antihypertensive (%)                    1815          (   21.8   )                     457    (    15.4     )                  1358       (   25.3   )               \<0.001
   Glucose lowering (%)                    355           (   4.3    )                     69     (     2.3     )                   286       (   5.3    )               \<0.001
   Lipid lowering (%)                      871           (   10.4   )                     339    (    11.5     )                   532       (   9.9    )                0.025

Triglycerides, C-reactive protein, and UAER were expressed as median (interquartile range).

###### 

Spearman's correlation coefficients with d-ROMs and BAP

                         **d-ROM**   **BAP**          
  --------------------- ----------- --------- ------- ---------
  Whole subjects                                      
   d-ROM                    \-                 0.19    \<0.001
   BAP                     0.19      \<0.001    \-         
   Age                     0.10      \<0.001   0.00     0.813
   BSA                     −0.26     \<0.001   −0.11   \<0.001
   Serum creatinine        −0.26     \<0.001   −0.03    0.002
   C-reactive protein      0.31      \<0.001   −0.04   \<0.001
   eGFR                    0.03       0.013    −0.04    0.001
   UAER                    0.19      \<0.001   −0.01    0.285
  Women                                               
   d-ROM                    \-                 0.16    \<0.001
   BAP                     0.16      \<0.001    \-         
   Age                     0.10      \<0.001   0.03     0.112
   BSA                     0.08      \<0.001   −0.01    0.609
   Serum creatinine        −0.04      0.036    0.08    \<0.001
   C-reactive protein      0.41      \<0.001   −0.01    0.651
   eGFR                    0.00       0.877    −0.08   \<0.001
   UAER                    0.10      \<0.001   0.02     0.267
  Men                                                 
   d-ROM                    \-                 0.17    \<0.001
   BAP                     0.17      \<0.001    \-         
   Age                     0.10      \<0.001   −0.02    0.177
   BSA                     −0.03      0.012    −0.05   \<0.001
   Serum creatinine        −0.01      0.378    0.05    \<0.001
   C-reactive protein      0.38      \<0.001   −0.03    0.017
   eGFR                    −0.02      0.131    −0.04    0.006
   UAER                    0.16      \<0.001   −0.05   \<0.001

![**Correlation between log(eGFR), log(UAER) and d-ROM levels.** Spearman's correlation analysis was performed. **A**. Correlation between log(eGFR) and d-ROM in women. **B**. Correlation between log(UAER) and d-ROM in women. **C**. Correlation between log(eGFR) and d-ROM in men. **D**. Correlation between log(UAER) and d-ROM in men.](1471-2369-14-191-1){#F1}

![**Correlation between log(eGFR), log(UAER) and BAP levels.** Spearman's correlation analysis was performed. **A**. Correlation between log(eGFR) and BAP in women. **B**. Correlation between log(UAER) and d-BAP in women. **C**. Correlation between log(eGFR) and d-BAP in men. **D**. Correlation between log(UAER) and d-BAP in men.](1471-2369-14-191-2){#F2}

Multivariate analysis
---------------------

We investigated the association between oxidant status markers and various variables including eGFR quartiles (the highest eGFR quartile was used as the reference), UAER quartiles (the lowest UAER quartile was used as the reference), age, high blood pressure, antihypertensive drugs use, and smoking status (Figures [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). In this model, the third and fourth UAER quartiles showed significant association with top d-ROM quartile (≥ 376 Carr units) in both genders. In addition, the second through fourth UAER quartiles were associated with the bottom BAP quartile (\< 2263 μmol/L) in men. On the other hand, in men, the first eGFR quartile was negatively associated with the top d-ROM quartile or with the bottom BAP quartile.

![**Logistic regression analysis examining the association between various parameters and the top d-ROM quartile. A**. Association of various parameters with the top d-ROM quartile in women. **B**. Association of various parameters with the top d-ROM quartile in men. For former and current smoking, never smoking was used as reference. For eGFR and UAER quartiles, the fourth eGFR quartile and the first UAER quartile, respectively, was used as reference.](1471-2369-14-191-3){#F3}

![**Logistic regression analysis examining the association between various parameters and the bottom BAP quartile. (A)** Association of various parameters with the bottom BAP quartile in women. **(B)** Association of various parameters with the bottom BAP quartile in men. For former and current smoking, never smoking was used as reference. For eGFR and UAER quartiles, the fourth eGFR quartile and the first UAER quartile, respectively, was used as reference.](1471-2369-14-191-4){#F4}

When C-reactive protein (CRP) was added as one of the covariates of the above statistical model, odds ratio of the lowest eGFR or the highest UAER quartile for the top d-ROM quartile or for the bottom BAP quartile was essentially unchanged, except the loss of significant association between the fourth UAER quartile and the top d-ROM quartile in women (Table [3](#T3){ref-type="table"}). In this model, CRP was found to be significantly associated with the top d-ROM quartile in both genders, whereas it did not show significant association with the bottom BAP quartile in either gender.

###### 

Odds ratio for the top d-ROM or the bottom BAP quartile before and after including CRP levels as one of the covariates

  **Dependent variable**     **Independent variable**    **Odd ratios**   **(**   **95%**   **)**   **P value**  
  -------------------------- -------------------------- ---------------- ------- --------- ------- ------------- ---------
  The top d-ROM quartile     Women                                                                               
   Model 1                                                                                                       
  The first eGFR quartile    0.83                              (          0.66      \-      1.04         )         0.100
  The fourth UAER quartile   1.34                              (          1.04      \-      1.75         )         0.023
   Model 2                                                                                                       
  The first eGFR quartile    0.81                              (          0.64      \-      1.02         )         0.079
  The fourth UAER quartile   1.16                              (          0.18      \-      1.52         )         0.268
  Men                                                                                                            
   Model 1                                                                                                       
  The first eGFR quartile    0.80                              (          0.64      \-      1.00         )         0.045
  The fourth UAER quartile   1.83                              (          1.48      \-      2.26         )        \<0.001
   Model 2                                                                                                       
  The first eGFR quartile    0.78                              (          0.62      \-      0.98         )         0.034
  The fourth UAER quartile   1.68                              (          1.35      \-      2.10         )        \<0.001
  The bottom BAP quartile    Women                                                                               
   Model 1                                                                                                       
  The first eGFR quartile    0.93                              (          0.70      \-      1.22         )         0.589
  The fourth UAER quartile   0.99                              (          0.72      \-      1.36         )         0.927
   Model 2                                                                                                       
  The first eGFR quartile    0.93                              (          0.71      \-      1.23         )         0.617
  The fourth UAER quartile   1.00                              (          0.73      \-      1.38         )         0.994
  Men                                                                                                            
   Model 1                                                                                                       
  The first eGFR quartile    0.77                              (          0.64      \-      0.93         )         0.005
  The fourth UAER quartile   1.36                              (          1.14      \-      1.63         )         0.001
   Model 2                                                                                                       
  The first eGFR quartile    0.77                              (          0.64      \-      0.93         )         0.005
  The fourth UAER quartile   1.37                              (          1.15      \-      1.64         )        \<0.001

In model 1, variables used in Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"} were used as dependent variables (age, high blood pressure, hypertensive drug use, smoking status, eGFR quartiles, UAER quartiles). In model 2, CRP levels were added as one of the independent variables to model 1.

Next, we analyzed the whether albuminuria or low eGFR was associated with the top d-ROM quartile or with the bottom BAP quartile (Figure [5](#F5){ref-type="fig"}). After adjusting for age, high blood pressure, antihypertensive drug use, and smoking status, micro-and macro-albuminuria was associated significantly and borderline significantly, respectively, with the top d-ROM quartile in men, when normo-albuminuria (UAER \< 30 mg/g·creatinine) was used as reference. After adjusting for the same variables, low eGFR (eGFR \< 60 mL/min/1.73 m^2^) was not significantly associated with the top d-ROM quartile in women (odds ratio, 0.86, 95% CI 0.67-1.10) or in men (odds ratio, 0.91, 95% CI 0.74-1.13) when eGFR ≥ 60 mL/min/1.73 m^2^ was used as reference. Similarly, low eGFR (eGFR \< 60 mL/min/1.73 m^2^) was not significantly associated with the bottom BAP quartile in women (odds ratio, 0.89, 95% CI 0.65-1.23) or in men (odds ratio, 0.84, 95% CI 0.70-1.01).

![**Logistic regression analysis examining the association between micro-and macro-albuminuria and the top d-ROM and the bottom BAP quartile. A**. Association of various parameters with the top d-ROM quartile in women. **B**. Association of various parameters with the top d-ROM quartile in men. **C**. Association of various parameters with the bottom BAP quartile in women. Because of the low prevalence of macro-albuminuria in women, both micro-and macro-albuminuria was combined for the statistical analysis. **D**. Association of various parameters with bottom BAP quartile in men. For former and current smoking, never smoking was used as reference. For micro-and macro-albuminuria, normo-albuminuria (UAER \< 30 mg/g·creatinine) was used as reference.](1471-2369-14-191-5){#F5}

Discussion
==========

We found that, when the lowest UAER quartile (\< 3.3 mg/g·creatinine) was used as reference, the higher two quartiles of UAER were positively associated with the top d-ROM quartile in both genders, and the higher three UAER quartiles were associated with the bottom BAP quartile in men, although the association between albuminuria and higher d-ROMs was weaken by the adjustment for CRP levels in women. These data indicate that increased UAER was associated with unfavorable oxidant status---high d-ROMs and/or low BAP---even in a range of normo-albuminuria (\< 30 mg/g·creatinine). On the other hand, the first eGFR quartile (eGFR \< 65.1 mL/min/1.73 m^2^) was associated, unexpectedly, negatively with the top d-ROM quartile in men.

Relationship between eGFR, d-ROMs, and BAP levels
-------------------------------------------------

Several previous studies have analyzed the relationship between oxidative stress and renal function. By analyzing the data of community-dwelling men, Nerpin et al. showed that low eGFR was associated with the several inflammatory markers, such as CRP, interleukin 6 (IL-6) and serum amyloid A (SAA); however, low eGFR was associated with lower urinary F2-isoprostanes \[[@B23]\]. Similarly, Upadhyay et al. found in the Framingham Offspring Study that individuals with reduced renal function had lower urinary isoprostanes than those without \[[@B24]\]. These unexpected associations between reduced renal function and oxidant status might be owing to the fact that F2-isoprostanes were quantified not in plasma, but in urine \[[@B25]\]. On the other hand, however, Oberg et al. showed that plasma carbonyl or F2-isoprostaine did not closely correlate with eGFR \[[@B26]\]. By contrast, Rebholz et al. showed that patients with low eGFR had increased plasma fluorescent oxidation products, an oxidative stress marker that reflects oxidation products generated from several pathways including lipid, protein, DNA and carbohydrate oxidation \[[@B27]\]. Thus, it is possible that the type of biomarkers used may influence the result of the association of eGFR and oxidative stress.

Similar to the current study, Fukui et al. analyzed the relationship between serum creatinine and oxidant status markers in individuals undergoing general health screening, and found that subjects with higher serum creatinine, thus those with lower eGFR, had lower d-ROMs \[[@B12]\], which can be said to be comparable to the current study. Fukui et al. discussed that this may be attributed to the gender difference in d-ROM level. In the current study, however, negative association between the lowest eGFR quartile and the top d-ROM quartile was statistically significant in men, and borderline significant in women.

Low eGFR (\< 60 mL/min/1.73 m^2^) was not found to be associated with the top d-ROM quartile in men, when eGFR of ≥ 60 mL/min/1.73 m^2^ was used as reference. On the other hand, the first eGFR quartile (\< 65.1 mL/min/1.73 m^2^) was significantly negatively associated with the top d-ROM quartile when the fourth eGFR quartile (≥ 82.6 mL/min/1.73 m^2^) was used as reference (Figure [3](#F3){ref-type="fig"}).

Relationship between UAER, d-ROMs, and BAP levels
-------------------------------------------------

Rashidi et al. found that proteinuria was associated with malondialdehyde levels, but not with oxidized low-density lipoproteins, in diabetic subjects \[[@B28]\]. In addition, Prior et al. showed that, in subjects with longstanding diabetes, plasma total antioxidant status did not differ according to the albuminuric status \[[@B29]\]. Furthermore, in the above-mentioned study, Nerpin et al. found that albuminuria was positively associated with several inflammatory markers including CRP, IL-6 and SAA; however, like reduced eGFR, increased albuminuria was associated with lower levels of urinary F2-isoprostanes in the study cohort \[[@B23]\]. As discussed above, this might be because urinary, but not plasma, F2-isoprostaines levels were measured in Nerpin et al.'s study. On the other hand, experimental studies showed albumin exposure will enhance the oxidative stress levels in the tubular cells. Souma et al. showed that oleic acid--bound albumin treatment may lead to an increased superoxide production in the proximal tubular cell line \[[@B30]\], and, in addition, Takao et al. showed that albumin treatment significantly increased 8-hydroxy-2′-deoxyguanosine levels in the culture media of the proximal tubular epithelial cells \[[@B31]\]. Therefore, it is possible that relationship between albuminuria and oxidative stress markers may, again, depend on the type of used biomarkers.

In the current study, it was found that, in men, either micro-or macro-albuminuria was associated with an increased odds for the bottom BAP quartile when normo-albuminuria was used as reference. It should also be noted that men with UAER of ≥ 3.3 mg/g·creatinine already had increased risk of having the bottom BAP quartile when compared with those with UAER of \< 3.3 mg/g·creatinine (Figure [4](#F4){ref-type="fig"}B). In other words, men with UAER of ≥ 3.3 mg/g·creatinine, which is within normo-albuminuria range, already had increased risk for decreased BAP compared with those with UAER of \< 3.3 mg/g·creatinine. We may have to be aware of this point when analyzing the relationship between albuminuria and antioxidant potential levels.

It has been reported that d-ROM levels showed positive association with CRP levels \[[@B19]\]. We therefore added CRP as one the covariates for the statistical model (Table [3](#T3){ref-type="table"}); however, essentially the same results were obtained even after the further adjustment for CRP, except for the association between UAER and d-ROMs in women.

The current study has some limitations. First, although anti-hypertensive drug use was found to be positively associated with higher BAP, we did not have data regarding the type of anti-hypertensive medication used. Second, information regarding whether individuals were taking any anti-oxidative supplements, such as vitamin C and E, was not available. Third, although measurement of the d-ROMs and BNP is feasible for the assessment of oxidant status in a large scale population, different association between renal parameters and oxidant status biomarkers may be obtained according to the types of oxidative stress measurement used \[[@B32]\]. Fourth, although the eGFR equation used was validated by assessing the population aged 18 years or older, it was derived from mostly from patients with chronic kidney disease \[[@B22]\]. Thus, eGFR calculation may have certain inaccuracy when applying essentially healthy subjects, as has been done in the current study.

Conclusion
==========

In summary, by analyzing data from individuals who underwent general health screening, we found that albuminuria was associated with increased oxidative stress in both genders and low antioxidant potential in men, and the association between albuminuria and higher d-ROMs may be weaken by the adjustment for CRP levels in women. On the other hand, low eGFR was associated positively with low BAP levels, whereas, unexpectedly, negatively with high d-ROMs in men. Whether life-style modification and drug intervention alter these oxidant status markers awaits further investigation.
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